HEMOGENIX Trademark

Trademark Overview

On Wednesday, January 19, 2005, a trademark application was filed for HEMOGENIX with the United States Patent and Trademark Office. The USPTO has given the HEMOGENIX trademark a serial number of 78549759. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, December 8, 2015. This trademark is owned by Hemo Genix, Inc.. The HEMOGENIX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and testing of drugs and compounds for their effects on the blood system
hemogenix

General Information

Serial Number78549759
Word MarkHEMOGENIX
Filing DateWednesday, January 19, 2005
Status800 - REGISTERED AND RENEWED
Status DateTuesday, December 8, 2015
Registration Number3041757
Registration DateTuesday, January 10, 2006
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2005

Trademark Statements

Pseudo MarkHEMOGENICS
Goods and Servicesresearch and testing of drugs and compounds for their effects on the blood system

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 28, 2005
Primary Code042
First Use Anywhere DateWednesday, March 1, 2000
First Use In Commerce DateWednesday, March 1, 2000

Trademark Owner History

Party NameHemo Genix, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressColorado Springs, CO 80906
Party NameHemo Genix, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressColorado Springs, CO 80907
Party NameHemo Genix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressColorado Springs, CO 80907

Trademark Events

Event DateEvent Description
Thursday, August 18, 2005ASSIGNED TO EXAMINER
Friday, August 19, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 28, 2005NEW APPLICATION ENTERED
Tuesday, October 18, 2005PUBLISHED FOR OPPOSITION
Tuesday, January 10, 2006REGISTERED-PRINCIPAL REGISTER
Monday, May 2, 2011APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 26, 2005ASSIGNED TO LIE
Monday, August 29, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 28, 2005NOTICE OF PUBLICATION
Friday, May 1, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 22, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 22, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 2, 2011TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 28, 2011NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, December 8, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, November 10, 2011TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 29, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 27, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, December 28, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, October 13, 2015TEAS SECTION 8 & 9 RECEIVED
Tuesday, December 8, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 8, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, December 8, 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, January 10, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

hemogenix effects blood system their compounds testing drugs research